Mercy Offers New Hereditary Cancer Testing for High-Risk Patients
A screening tool aims to identify patients at high risk for cancer who may benefit from germline or hereditary DNA testing.
Latest Articles
Editor's Top Picks
FDA Clears Automated Platform for Multiple Myeloma Diagnosis
The system combines enhanced sensitivity with automation to detect M-proteins at low concentrations, supporting early diagnosis of plasma cell disorders.
Be the First to Know What’s Next in the Lab
Every week, we dig into the biggest shifts, breakthroughs, and tech transforming clinical diagnostics. Straightforward, insightful, and always relevant.Critical Resources
Diagnostic Innovations
Revvity to Acquire ACD/Labs to Expand Research Informatics Portfolio
The acquisition adds analytical characterization and molecular design software capabilities to Revvity Signals' platform.
Equipment & Supply Spotlight
Digital Twin Applications in Lab Automation to Be Explored at SLAS Event
E Tech Group's Sura Hadi will facilitate discussion on practical implementation and maturity levels of digital twin technology in laboratory design.
News, Know-How & Standards
Disease Detection & Understanding
Multi-Cancer Blood Test Could Significantly Reduce Late-Stage Diagnoses
A simulation model shows that annual liquid biopsy screening would increase early-stage cancer detection by up to 30% while cutting stage IV diagnoses by 45%.
